Leaders | The Inflation Reduction Act

America’s climate-plus spending bill is flawed but essential

The green policies and drug reforms in the Inflation Reduction Act are big victories

United States President Joe Biden talks to members of the press as he walks on the South Lawn of the White House before boarding Marine One, on August 7, 2022 in Washington, DC. Biden is traveling to Rehoboth Beach, Delaware, after he tested negative from COVID 19. Credit: Oliver Contreras / Pool via CNP

After a long path through Congress, a giant tax-and-spend package is on the verge of being passed by Democrats. It will be America’s first significant climate law and a cornerstone of President Joe Biden’s agenda. Just weeks ago the bill seemed dead, but a backroom deal brought it back to life. It cleared the Senate along party lines by a single vote. The House looks set to approve it on August 12th, after we go to press (see United States section). As a feat of legislative legerdemain, it is impressive.

This article appeared in the Leaders section of the print edition under the headline “Climate policy, at last”

The new Germany

From the August 13th 2022 edition

Discover stories from this section and more in the list of contents

Explore the edition

More from Leaders

Keir Starmer surrounded by the Eu stars

Sir Keir Starmer should aim higher in his reset with the EU

And he needs to be clearer about what Britain wants

illustration of a world map outlined by a single red electrical cord, with a plug at one end and a socket at the other

To make electricity cheaper and greener, connect the world’s grids

Less than 3% of the world’s power is internationally traded—a huge wasted opportunity


Chinese AI is catching up, posing a dilemma for Donald Trump

The success of cheap Chinese models threatens America’s technological lead


America has an imperial presidency

And in Donald Trump, an imperialist president for the first time in over a century

Tariffs will harm America, not induce a manufacturing rebirth

Donald Trump’s pursuit of tariffs will make the world poorer—and America, too 

How to improve clinical trials

Involving more participants can lead to new medical insights